Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3411556rdf:typepubmed:Citationlld:pubmed
pubmed-article:3411556lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3411556lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:3411556lifeskim:mentionsumls-concept:C0024156lld:lifeskim
pubmed-article:3411556lifeskim:mentionsumls-concept:C0033308lld:lifeskim
pubmed-article:3411556lifeskim:mentionsumls-concept:C0014912lld:lifeskim
pubmed-article:3411556lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3411556lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:3411556pubmed:issue2lld:pubmed
pubmed-article:3411556pubmed:dateCreated1988-10-13lld:pubmed
pubmed-article:3411556pubmed:abstractTextCell suspensions were prepared from human corpora lutea obtained during the mid-luteal phase. Progesterone production was assessed after short-term incubation of luteal cell suspensions. Luteal cells were very sensitive to hCG, the concentration required for 50% maximum response being 0.01 i.u./ml, and the response was 5 times higher than the basal production. Oestradiol (1-100 microM) induced a significant dose-related decrease in both basal and hCG-stimulated progesterone production. The A-nor steroidal compounds anordrin and AF-45 reduced hCG-stimulated progesterone production only at the high concentration of 100 microM. The ED50 values were approximately 3 microM, 75 microM and 100 microM for oestradiol, AF-45 and anordrin respectively. Anordrin showed no significant effects on basal progesterone production. In addition, oestradiol markedly inhibited the activity of 3 beta-hydroxysteroid dehydrogenase in luteal cells, expressed by the conversion of pregnenolone to progesterone, but the inhibitory effects of anordrin and AF-45 were negligible or relatively low. The effects of anordrin and AF-45 were different from those of oestradiol on progesterone production by human luteal cells in vitro, indicating that neither substance is likely to be a useful luteolytic agent in women.lld:pubmed
pubmed-article:3411556pubmed:languageenglld:pubmed
pubmed-article:3411556pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:citationSubsetIMlld:pubmed
pubmed-article:3411556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411556pubmed:statusMEDLINElld:pubmed
pubmed-article:3411556pubmed:monthJullld:pubmed
pubmed-article:3411556pubmed:issn0022-4251lld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:NoeL JLJlld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:VAHSWWlld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:ZhouWWlld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:OLOlld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:ShenW XWXlld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:WuY FYFlld:pubmed
pubmed-article:3411556pubmed:authorpubmed-author:ZhouM RMRlld:pubmed
pubmed-article:3411556pubmed:issnTypePrintlld:pubmed
pubmed-article:3411556pubmed:volume83lld:pubmed
pubmed-article:3411556pubmed:ownerNLMlld:pubmed
pubmed-article:3411556pubmed:authorsCompleteYlld:pubmed
pubmed-article:3411556pubmed:pagination647-53lld:pubmed
pubmed-article:3411556pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:meshHeadingpubmed-meshheading:3411556-...lld:pubmed
pubmed-article:3411556pubmed:year1988lld:pubmed
pubmed-article:3411556pubmed:articleTitleEffect of A-nor steroids and oestradiol on progesterone production by human luteal cells.lld:pubmed
pubmed-article:3411556pubmed:affiliationShanghai Institute of Planned Parenthood Research, China.lld:pubmed
pubmed-article:3411556pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3411556pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed